Abstract
Aim
There is accumulative evidence indicating that targeting antigen presenting cells (APCs) with different types of adjuvants could result in the induction of antitumor immune responses. It has been hypothesized that APCs function may be altered in the elderly contributing to a decline in the immune function. We evaluated whether targeting APCs following injection with Poly I:C, LPS, flagellin, imiquimod and CpG-ODN would induce an antitumor response in the old.
Materials and methods
The immune and antitumor responses induce Poly I:C, LPS, flagellin, imiquimod and CpG-ODN were compared in young (2 month old) and old (18 months) mice.
Results
Our results indicated that only intratumoral (i.t.) injections of CpG-ODN completely rejected the tumor in both young and old mice. Injections of Poly I:C also induced the rejection of tumors in the young but not in the old. Furthermore, i.t. injections of CpG-ODN promoted the development of protective memory responses in the young and the old. Analysis of the immune responses in the old indicated that CpG-ODN but not Poly-I:C induces: a pro-inflammatory Th1 type response; accumulation and activation of CD4+, CD8+ T and, NK cell responses; activation of APCs; and reduction in the number of Tregs. The activation of these immune-parameters positively correlates with the induction of an antitumor response.
Conclusions
These studies indicate that there are differences in the level of stimulation with TLR-ligands between young and old APCs and that the aged immune responses can be rescued and exploited for the induction of tumor immunity by targeting APCs with specific TLR-ligands. These results have important clinical implications for developing immunization strategies containing TLR-ligands that will be effective in both the young and old.
Similar content being viewed by others
References
Alignani DO, et al (2005) Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J Leukoc Biol 77:898–905
Baines J, Celis E (2003) Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides. Clin Cancer Res 9(7):2693–2700
Bhattacharyya S, et al (2004) Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the P13K/Akt pathway and of IkappaB kinase activity. Blood 104(4):1100–1109
Caslte SC, et al (1999) Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12. Exp Gerontol 34(2):243–252
Castle SC, et al (1999) Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev 107:137–145
Cuadros C, et al (2004) Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses in aged animals. J Immunol 72:2810–2816
Deng Y, et al (2004) Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 172(6):3437–3446
Edwards AD, et al (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33(4):827–833
Esche C, Shurin MR, Lotze MT (1999) The use of dendritic cells for cancer vaccination. Curr Opin Mol Ther 1(1):72–81
Forsey RJ, et al (2003) Plasma cytokine profiles in elderly humans. Mech Ageing Dev 124(4):487–493
Foster BA, et al (1997) Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 57(16):3325–3330
Grewe M (2001) Chronological ageing and photoageing of dendritic cells. Clin Exp Dermatol 26:608–612
Hawlisch H, Kohl J (2006) Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 43:13–21
Janeway CA Jr, et al (1989) Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection. Cold Spring Harb Symp Quant Ciol 54(Pt 2):657–666
Kadowaki N, et al (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194:863–869
Kaisho T, Akira S (2003) Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 3:373–385
Lin W, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175–1183
Lung TL, et al (2000) Unimpaired dendrititc cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18:1606–1612
Lustgarten J, Dominguez AL, Thoman M (2004) Aged mice develop protective antitumor immune responses with appropriate costimulation. J Immunol 173:4510–4515
Maletto B, et al (2002) CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. J Leukoc Biol 72(3):447–454
Martin M, et al (2003) Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol 171(2):717–725
Matsushima H, et al (2004) TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 173(1):531–541
Norian LA, Allen PM (2004) No intrinsic deficiencies in CD8+ T cell-mediated antitumor immunity with aging. J Immunol 173:835–844
Osada T, et al (2006) Dendritic cell-based immunotherapy. Rev Immunol 25:377–413
Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033–1036
Plowden JM, et al (2004) Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function. Cell Immunol 229:86–92
Renshaw M, et al (2002) Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 169:4697–4701
Rovero S, et al (2000) DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. Infect Immun 72:2810–2816
Salem ML, et al (2005) Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity. J Immunother 28(3):220–228
Sandmand M, et al (2002) Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans? Clin Exp Immunol 127(1):107–114
Saurwein-Teissl M, Romani N, Grubeck-Loebenstein B (2000) Dendritic cells in old age neglected by gerontology? Mech Ageing Dev 121:123–130
Sharma S, Dominguez AL, Lustgarten J (2006) Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 41:78–84
Sharma S, Dominguez AL, Lustgarten J (2006) High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol 177(12):8348–8355
Sun J, et al (2005) TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J Immunol 174(2):742–751
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
Tamir A, et al (2007) Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunol Immunother (in press). doi:10.1007/s00262-007-0299-y
Tan T, Coussens L (2007) Humoral immunity, inflammation and cancer. Curr Opin Immunol 19(2):209–216
Tortorella C, et al (2002) APC-dependent impairment of T cell proliferation in aging: role of CD28- and IL-12/IL-15-mediated signaling. Mech Ageing Dev 123:1389–1402
Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7(3):179–190
Vargas A, et al (2003) Age-dependent changes in thymic macrophages and dendritic cells. Microsc Res Tech 62:501–507
Xu D, Liu H, Komai-Koma M (2004) Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell Mol Immunol 1(4):239–246
Acknowledgements
This work was supported by Grant CA78579 and AG028751 (to J. L.) from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, S., Dominguez, A.L., Hoelzinger, D.B. et al. CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged. Cancer Immunol Immunother 57, 549–561 (2008). https://doi.org/10.1007/s00262-007-0393-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-007-0393-1